Sunshine Biopharma, Inc.
SBFM
$2.18
$0.041.87%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.24M | -2.14M | -883.80K | -1.77M | -1.18M |
| Total Depreciation and Amortization | 76.90K | 98.60K | 96.20K | 72.50K | 64.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 142.00K | 554.70K | 1.06M | -- |
| Change in Net Operating Assets | -905.10K | 284.30K | -494.80K | -636.90K | -580.00K |
| Cash from Operations | -2.07M | -1.62M | -727.80K | -1.27M | -1.70M |
| Capital Expenditure | -5.10K | 1.00K | -8.00K | -160.00K | -7.50K |
| Sale of Property, Plant, and Equipment | -- | -10.30K | 10.30K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99.40K | -41.00K | -120.50K | -331.80K | -204.50K |
| Cash from Investing | -104.50K | -50.20K | -118.30K | -491.80K | -212.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 75.50K | -58.40K | -- |
| Issuance of Common Stock | -- | 724.50K | 0.00 | 3.67M | 355.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 724.50K | 75.50K | 3.61M | 355.30K |
| Foreign Exchange rate Adjustments | -33.70K | 758.60K | -228.30K | 335.70K | -10.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | 0.00 | -- |
| Net Change in Cash | -2.21M | -183.10K | -998.90K | 2.18M | -1.56M |